- Home
- AUPH vs RWT Comparison
AUPH vs RWT Comparison
Compare AUPH & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- RWT
- Stock Information
- Founded
- AUPH 1993
- RWT 1994
- Country
- AUPH Canada
- RWT United States
- Employees
- AUPH N/A
- RWT N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- RWT Real Estate Investment Trusts
- Sector
- AUPH Health Care
- RWT Real Estate
- Exchange
- AUPH Nasdaq
- RWT Nasdaq
- Market Cap
- AUPH 1.1B
- RWT 756.1M
- IPO Year
- AUPH 1999
- RWT 1995
- Fundamental
- Price
- AUPH $7.48
- RWT $6.04
- Analyst Decision
- AUPH Strong Buy
- RWT Buy
- Analyst Count
- AUPH 2
- RWT 11
- Target Price
- AUPH $11.50
- RWT $7.59
- AVG Volume (30 Days)
- AUPH 1.5M
- RWT 1.1M
- Earning Date
- AUPH 07-31-2025
- RWT 07-31-2025
- Dividend Yield
- AUPH N/A
- RWT 11.92%
- EPS Growth
- AUPH N/A
- RWT 105.35
- EPS
- AUPH 0.27
- RWT 0.21
- Revenue
- AUPH $247,295,000.00
- RWT $241,796,000.00
- Revenue This Year
- AUPH $12.15
- RWT N/A
- Revenue Next Year
- AUPH $18.31
- RWT $3.43
- P/E Ratio
- AUPH $28.08
- RWT $28.64
- Revenue Growth
- AUPH 29.20
- RWT 29.65
- 52 Week Low
- AUPH $5.20
- RWT $4.68
- 52 Week High
- AUPH $10.67
- RWT $8.15
- Technical
- Relative Strength Index (RSI)
- AUPH 37.50
- RWT 65.36
- Support Level
- AUPH $7.71
- RWT $5.40
- Resistance Level
- AUPH $8.86
- RWT $5.72
- Average True Range (ATR)
- AUPH 0.34
- RWT 0.16
- MACD
- AUPH -0.00
- RWT 0.05
- Stochastic Oscillator
- AUPH 2.13
- RWT 92.09
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.